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Abstract
Background: Healthy Alberta Communities (HAC) was a 3-year community-based intervention to reduce lifestyle-related
risk factors for chronic disease and obesity at a population-level. The current paper examines changes in blood pressure
(BP) and anthropometric indicators within HAC communities compared to secular trends.
Methods: Between 2006 and 2009, this community-academic partnership sought to create environments supportive of
healthier dietary and physical activity behaviours within four diverse communities in Alberta, Canada. Height, weight,
waist and hip circumference and BP were measured among 1554 and 1808 community residents at baseline (2006)
and follow-up (2009), respectively. A comparison sample was drawn from a representative national survey. Samples
were stratified by age and change between pre- and post-intervention was assessed using t-tests. Changes in
parameters over time between groups were compared using meta-analysis. The net difference in change in outcomes
(change in intervention communities minus change in comparison group) represented the effect of the intervention.
Results: Adjusted systolic (SBP) and diastolic (DBP) BP declined within most age groups in HAC communities
from pre- to post-intervention. The net decline in SBP was 1 mmHg in 20–39 year olds (p = 0.006) and 2 mmHg
in 40–59 year olds (p = 0.001), while the net decline in DBP was 3 mmHg in 20–39 year olds (p < 0.001), 2 mmHg
in 40–59 year olds (p < 0.001) and 3 mmHg in 60–79 year olds (p < 0.001). The net increase in the proportion of
individuals with normal BP was 5.9 % (p < 0.001), while the net decline in the proportion of individuals with stage
1 hypertension was 4.5 % (p < 0.001). BMI and body weight were unchanged. There was a significant net increase
in waist and hip circumference among 20–39 year olds within intervention communities.
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Conclusions: Findings suggest HAC succeeded in shifting the population distribution of BP in a leftward direction. By
contrast, anthropometric parameters remained unchanged or worsened within intervention communities. Therefore,
while improvements in some clinical risk factors can be achieved through relatively diffuse and shorter-term
community-level environmental changes, improvements in others may require interventions of greater intensity
and duration. Evaluating the success of community-based interventions based on their efficacy in changing
individual-level clinical indicators may, however, underestimate their potential.
Keywords: Community-based intervention, Systolic blood pressure, Diastolic blood pressure, Blood pressure,
Hypertension prevention, Obesity, Anthropometric measures, Chronic disease prevention
Background
Chronic diseases are the most important cause of
morbidity and mortality worldwide. The major chronic
diseases—cancer, cardiovascular disease, diabetes and
chronic pulmonary disease now account for 63 % of all
annual global deaths [1]. Similarly in Canada, cardiovas-
cular diseases and cancer represent approximately 58 %
of annual deaths [2]. Of the major chronic diseases,
cardiovascular diseases, including conditions such as is-
chaemic heart disease, coronary heart disease, stroke,
congestive heart failure, and end-stage renal disease, are
the most prevalent and are on the rise [3, 4]. High blood
pressure (BP), both systolic (SBP) and diastolic (DBP),
has been repeatedly identified as the most universal
strong, consistent, continuous, independent, and etio-
logically relevant contributor to cardiovascular diseases
[5–8], and is responsible for 7 % of global disability-
adjusted life years lost [9].
Obesity increases the risk of chronic disease, and in-
deed rates of obesity and chronic disease have risen in
tandem over the past several decades [1, 4, 10]. In 2008,
more than half a billion adults were obese worldwide [1],
including 27.2 % of Canadian adults [11]. Chronic diseases
and obesity are linked by two major shared, lifestyle-
related preventable risk factors of unhealthy diets and
insufficient physical activity [1, 3]. The disease burden
attributable to unhealthy diets is particularly high [3].
In 2010, seven of the top 20 deaths and disabilities
worldwide were related to poor diet [4], with excessive
salt consumption and inadequate fruit and vegetable
intake contributing 10 % of the total global burden of
disease [9]. In Canada, it is estimated that 30,540 deaths
could be averted annually if Canadians adhered to dietary
recommendations [12]. Dietary factors, including low
fruit, vegetable and potassium intakes, and excessive alco-
hol and sodium intakes are also major preventable causes
of high BP, along with excess body weight and insufficient
physical activity [13, 14].
Although the behavioural origins of chronic disease
and obesity are clear, the drivers of these behaviours are
varied and complex, and thus no nation has succeeded
in reversing their high prevalence [15]. Factors at all
levels interact to shape individual health behaviours, and
therefore success in chronic disease and obesity preven-
tion will require ecological approaches through multi-
sectoral, multi-level, population-wide interventions [16].
Community-based interventions adopt an explicitly eco-
logical approach to health promotion through integrated
and comprehensive interventions targeting change among
individuals, groups and community-level environments
and policies [17, 18]. Their appeal stems largely from their
potential to produce widespread change, as even if they are
only modestly effective, small changes at a population-level
can confer significant health benefits [19]. Community-
based interventions are particularly appropriate to address
chronic disease and obesity given that these conditions
are so pervasive, affect all sociodemographic groups,
share lifestyle-related risk factors that are shaped by en-
vironments and policies, and require sustained behaviour
change for prevention [17].
The North Karelia Project in Finland stands out as
among the most successful of community-based interven-
tions. Through coordinated, multi-level policy and envir-
onmental change, the project is credited with achieving a
73 % reduction in age-adjusted coronary heart disease
mortality from 1971 to 1995 [20], the benefits of which
were still evident 35 years later [21]. Subsequent
community-based health promotion initiatives patter-
ned after the North Karelia approach have generally
yielded mixed, and more modest improvements in
population-level risk factors [18, 22]. A sizeable litera-
ture suggests that inadequate attention to contextual
factors [23], methodological issues (eg. low statistical
power, limitations of quasi-experimental designs, sampling
issues), the influence of secular trends, smaller than ex-
pected effect sizes, limitations of the interventions (eg. in-
sufficient duration and tailoring, low dose), absence of a
robust theoretical underpinning, and insensitive evalu-
ation tools may have contributed to disappointing results
from some community-based interventions [18, 24, 25].
The collective learnings from the successes and failures
of these studies suggest that best practice methods for
community-based interventions include multi-sectoral
partnerships, involving communities in program planning
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and implementation, tailored interventions, reduced ac-
cess to unhealthy products, involvement of the non-health
sector, addressing social inequalities in disease risk, coor-
dinated multi-level interventions, rigorous process evalu-
ation and a sufficient intervention dose [22, 26].
Healthy Alberta Communities (HAC) was a 3-year
community-based intervention that sought to leverage
lessons from past community-based interventions to
expand the evidence base related to chronic disease and
obesity prevention. The primary objective of this study
was to assess the impact of a community-based inter-
vention on risk factors for chronic disease and obesity.
Summaries of the study’s conceptual framework [27] and
overall findings (i.e. self-reported behavioural indicators,
social conditions and objectively measured clinical out-
comes) have been published [28]. Sense of belonging to
community and objectively-assessed BP were the only
measures in which improvements were observed in HAC
communities relative to secular trends. The current paper
examines changes in BP and anthropometric indicators
according to age within HAC communities compared to
secular trends. These more in-depth analyses were not re-
ported in previous publications.
Methods
Context and intervention
The methodological details of the study have been previ-
ously described [27, 28]. Briefly, HAC was a community-
academic partnership involving an intervention within
four communities in Alberta, a geographically large,
politically conservative, resource-rich province in West-
ern Canada. The Government of Alberta selected the
four communities to represent a range of demographic
and geographic characteristics. Bonnyville and St. Paul
were rural towns located in the northeastern part of the
province, with economies predicated on agricultural
and oil-field related activities. Norwood was a culturally
diverse, socio-economically disadvantaged inner-city
neighborhood located in Edmonton, Alberta’s capital
city. Medicine Hat was a small, resource-rich city in the
southeastern area of the province considered to be a
service centre for the southern half of the province.
Socio-demographic characteristics of the communities
are summarized in Raine et al. [28].
Four Community Coordinators with established com-
munity networks were hired to link the research team
with each community. During the initial years of the
study, Community Coordinators built relationships with
local stakeholders and worked with them to identify en-
vironmental determinants of chronic disease and obesity
amenable to change at a community-level. Subsequent
years focused on partnering with local individuals and
organizations to intervene in the targeted areas. Key ac-
complishments included the expansion of community
gardens, improved access to recreation and sport facilities,
development of a healthy choice restaurant program, a
program to provide subsidized local produce to food inse-




Baseline data for all HAC communities were collected
prior to intervention in spring, 2006, while follow-up
data were collected at the conclusion of the study in
spring, 2009. Data collection at both time points com-
prised three phases.
 Phase 1 was a cross-sectional telephone survey
administered by an independent survey research
firm. The survey took approximately 30 min to
complete and assessed lifestyle behaviours
(eg. diet, physical activity, smoking), health status
(including height and weight) and cognitive change
(intentions).
 Phase 2 involved physical measures of height,
weight, waist and hip circumference and BP at a
local measurement clinic. Participants were offered
free transportation, light refreshments and a $20
CDN gift card to a local grocery store in exchange
for participation. The clinics remained open 3–7
times per week (including evenings and weekends)
over a 16-week period.
 Phase 3 was conducted exclusively in Medicine Hat,
and consisted of blood collection by a phlebotomist
to measure fasting glucose, total cholesterol, high-
and low-density lipoprotein cholesterol levels and
triglycerides. The third phase of the study is not
discussed further in this paper as findings have
been published [28].
Participants
Although other indicators were also considered relevant,
the study was powered to detect a 1.5 % reduction in
BMI. Random samples of adults proportionate to the
number of inhabitants in each community were selected
to participate in the telephone surveys in 2006 and
2009. In Norwood, Edmonton, participants were ran-
domly selected from relevant postal code areas using
the telephone directory. In the other three communities
a Random Digit Dial sample frame was used to recruit
participants using historical telephone lists. Individuals
who participated in the survey were invited to attend
the measurement clinic in their community to provide
objective physical measures. Pregnant women and indi-
viduals in wheelchairs were excluded. The target and
achieved enrollment numbers are summarized in Table 1.
Lytvyak et al. BMC Public Health  (2016) 16:344 Page 3 of 15
A comparison sample for the physical measures was
drawn from the 2007–2009 and 2009–2011 waves of the
Canadian Health Measures Survey [11, 30]. This ap-
proach allowed the majority of research funds to be
channeled into intervening within the four HAC com-
munities, rather than into creating costly and somewhat
artificial, matched comparison communities. Although
we had intended to use all non-HAC communities
within Alberta as a comparison, the Alberta-based sam-
ple was too small [28], and therefore data were com-
pared to a national sample.
Ethical approval
The study was approved by the University of Alberta’s
Research Ethics Board. Respondents to the telephone
survey provided verbal consent to participate, while
those who participated in physical measures also pro-
vided written, informed consent.
Physical measurements
A trained measurement technician collected all anthropo-
metric (height, weight, waist and hip circumference) and
BP measurements according to standardized protocols.
To facilitate comparisons with the reference population,
all clinic procedures were adapted from the clinic proce-
dures protocol developed for the Canadian Health Mea-
sures Survey [31]. Prior to all measurements participants
removed their footwear, bulky clothing (gowns were
provided), belt, all objects from their pockets, and any
hair ornaments, jewellery, buns and braids from the top
of the head.
Table 1 Self-reported characteristics of participants in intervention communities who completed physical measurements at baseline
(2006) and follow-up (2009)
Parameters Baseline n = 1554 Follow-up n = 1808
mean ± SEM
Age, years 50.0 ± 0.4 54.0 ± 0.3
Age categories % (n)
18–39 years 27.9 (433) 18.1 (322)
20–39 years 27.5 (427) 18.1 (321)
40–59 years 42.7 (664) 44.9 (797)
60–79 years 27.2 (422) 33.5 (595)
≥ 80 years 2.3 (35) 3.4 (61)
Sex, female (%) 69.0(1073) 67.6 (1222)
Education, completed College/University 39.9 (619) 38.1 (687)
Employment status
Employed full-time 42.1 (655) 39.8 (720)
Employed part-time 17.7 (275) 16.1 (291)
Homemaker 12.1 (188) 9.4 (170)
Retired 24.5 (380) 30.4 (549)
Student 3.8 (59) 1.8 (33)
Temporarily unemployed 4.5 (70) 5.1 (92)
Volunteer 7.7 (120) 5.2 (94)
Level of combined household income, above cut-off pointsa 84.8 (1223) 87.8 (1490)
Perceived health, excellent and very good 54.0 (838) 54.1 (978)
Sense of belonging to local community, strong 73.3 (1121) 77.1 (1380)
Fruit and vegetable intake, ≥ 5 servings/dayb 49.5 (751) 46.9 (824)
Physical activity index, activec 36.7 (570) 22.4 (405)
High blood pressure 18.0 (279) 21.5 (387)
Use antihypertensive medication 16.8 (261) 19.5 (352)
Smoking status, daily 24.0 (254) 20.4 (246)
Data represent unweighted values
aLow income cut-offs are defined by Statistics Canada as income thresholds below which families devote a larger share of income to purchasing food, shelter and
clothing than average families. Low income cut-offs were calculated for each participant based on family size and community of residence [75]
bOne serving of fruits and vegetables was defined as a medium fruit or half a cup of fresh, frozen or canned vegetables [76, 77]
cActive was defined as a total average daily energy expenditure ≥ 3.0 kcal/kg/day [77]
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Blood pressure
BP was measured prior to completing any other physical
measures or completing any questionnaires. SBP and DBP
were measured in a seated position on the right arm of
each participant following a 15 min rest period using an ap-
propriately sized automated BP cuff (BpTRU Model 300,
BPTRU Medical Devices, Coquitlam, British Columbia,
Canada). Six BP measurements were taken. Mean BP
values were calculated by discarding the first, and aver-
aging the last five BP values. BP was classified as normal
(SBP < 130 mmHg and/or DBP < 85 mmHg), high-normal
(SBP = 130–139 mmHg and/or DBP = 85–89 mmHg),
or stage 1 hypertension (SBP = 140–159 mmHg and/or
DBP = 90–99 mmHg) based on standards from the
fifth report of the Joint National Committee on Detec-
tion, Evaluation and Treatment of High Blood Pres-
sure [32]. Data for individuals with SBP ≥ 160 mmHg
and DBP ≥ 90 mmHg were not considered as a com-
parison sample was not available (Canadian Health
Measures Survey data were considered unreliable due
to small sample sizes [11, 30]) .
Weight and height
Weight (to the nearest 0.1 lb) was measured using digital
scales (LifeSource UC-321 Precision Personal Health
Scale, Auto Control Medical Inc., Millcreek, Ontario,
Canada) that were calibrated daily prior to use. Partici-
pants were requested to stand in the centre of the scale,
with weight evenly distributed on both feet during the
measurement. Standing height was measured using a
portable stadiometer with a vertical backboard and a
moveable headboard (Seca 214 Road Rod Portable Stadi-
ometer, Seca, Chino, California, USA). Participants were
asked to stand tall with arms hanging at the sides, feet
together with weight evenly distributed between them,
and their heels, buttocks, back and head touching the
vertical backboard of the stadiometer. The measurement
technician aligned the participant’s head in the Frankfort
Plane and asked the participant to take a deep breath
and hold it while the measurement was taken and re-
corded to the nearest 0.1 cm.
Body mass index
BMI was calculated from measured height and weight
and classified as: normal weight (18.5–24.9 kg/m2), over-
weight (25.0–29.9 kg/m2), obese class I (30.0–34.9 kg/m2),
obese class II (35.0–39.9 kg/m2), and obese class III
(≥40.0 kg/m2) [33].
Waist and hip circumference, waist-to-hip ratio
Waist circumference was measured over light clothing
while participants stood erect in a relaxed manner with
arms hanging loosely at the sides, and weight evenly dis-
tributed between both feet. The measurement (to the
nearest 0.1 cm) was taken at the end of a normal expir-
ation at the mid-point between the bottom of the rib
cage and the top of the iliac crest using a measuring tape
(QM 2000 Measure Mate, Quick Medical, Issaquah,
Washington, USA). Hip circumference was measured in
the same manner, but at the maximal circumference of
the hips or buttocks region (whichever was larger), and
above the gluteal fold using the same measuring tape.
Statistical analyses
Descriptive statistics were calculated for the baseline and
follow-up samples and compared using t-tests. Weighting
and bootstrapping (with 300 iterations) of the phone sur-
vey databases were used to obtain accurate estimates of
variances. A series of logistic regressions were performed
to determine whether participants who provided physical
measurements were similar to those who participated
in the telephone survey. As the physical measures sub-
sample differed from the telephone survey sample on
community of residence, age category, smoking, BMI,
physical activity level, fruit and vegetable consumption,
and self-reported health, re-weighting and bootstrap-
ping (with 300 iterations) of the physical measures data
was required and adjustments were made based on the
survey weights calculated. The samples were stratified
by age, and change between pre- and post-intervention
time points in each of the age categories was assessed
for each outcome using two-tailed t-tests. A compari-
son sample for the physical measures was drawn from
the 2007–2009 and 2009–2011 waves of the Canadian
Health Measures Survey [11, 30]. Changes in parame-
ters over time between intervention and comparison
groups were compared using meta-analytic procedures
given that the analyzed data were from two different
samples. The net difference in the change in outcomes
(calculated as change in the intervention communities
minus change in the comparison group) represented
the effect of the intervention. Continuous data are pre-
sented as mean ± SEM with 95 % confidence intervals,
frequencies are presented as percentages. All analyses
were performed using SPSS (version 19.0, IBM Corpor-
ation, Armonk, NY, 2010), with p < 0.05 indicating
statistical significance.
Results
Response rates and participant characteristics
The total number of phone numbers in the sample in all
four HAC communities was 45212 in 2006 and 53785 in
2009. After excluding homes where the phone was not
answered, a total of 12659 (27.9 %) and 8767 (16.3 %)
people were asked to participate in the survey in 2006
and 2009, respectively. Of these, 4761 (2006) and 4733
(2009) individuals were eligible and completed the tele-
phone interview. This represents an overall response
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rate of 10.5 % in 2006 and 8.8 % in 2009, with 37.6 %
(2006) and 53.9 % (2009) of persons asked to complete
the survey doing so. Of those who completed the tele-
phone interview, valid physical measurement data were
obtained from 1554 adults in 2006 and 1808 in 2009
(32.6 % and 38.2 % of those who completed Phase 1
interviews in 2006 and 2009, respectively). Characteris-
tics of individuals from intervention communities who
completed physical measurements are presented in Table 1.
Socio-demographic characteristics of individuals within the
comparison group were not publicly available and are
therefore not reported.
Blood pressure
Changes in BP within intervention and comparison
groups from 2006–2009 are presented in Table 2. At
baseline, mean SBP and DBP values were higher in inter-
vention communities than in the comparison group.
There was a significant decline in the net adjusted SBP
and DBP within most age groups in HAC communities
from baseline to follow-up. The net decline in SBP was
1 mmHg in 20-39 year olds (p=0.006) and 2 mmHg in
40–59 year olds (p = 0.001) (Fig. 1), while the net decline
in DBP was 3 mmHg in 20–39 year olds (p < 0.001),
2 mmHg in 40–59 year olds (p < 0.001) and 3 mmHg in
60–79 year olds (p < 0.001; Fig. 2). As a result, at follow-
up mean SBP and DBP within intervention communities
was equal to, or lower than values in the comparison
group for all age categories, with the exception of SBP
values within the 20–39 year old age group.
The proportion of individuals with normal BP in-
creased significantly in intervention communities in all
age groups except the 60–79 year old group (Fig. 3). No
significant changes were observed within the comparison
group. Changes within intervention communities were
significantly greater than those in the comparison group
overall (p = 0.029), and within the 18–39 (p < 0.001) and
40–59 year old (p < 0.001) age categories. A correspond-
ing reduction in the proportion of individuals within
intervention communities with stage 1 hypertension was
also observed in all age groups except the 60–79 year
old group (Fig. 4). By contrast, values in the comparison
group were unchanged. The changes observed in inter-
vention communities were significantly greater than those
in the comparison group overall (p < 0.001), and for the
40–59 year old (p < 0.001) age categories. The outcome of
these shifts was a net increase in the proportion of
normotensive individuals of 4.0 % in the 18–39 year old
group (p = 0.029), of 8.6 % in the 40–59 year old group
(p < 0.001), and 5.9 % overall (p < 0.001), along with a
net decrease in the proportion of stage 1 hypertensive
individuals by 7.3 % among 40–59 year olds (p < 0.001)
and 4.5 % overall (p < 0.001).
Anthropometrics
There were no significant differences in body weight,
BMI or in the distribution of BMI from 2006–2009
within or between the intervention and comparison
groups (Table 2). Waist circumference increased signifi-
cantly among 20–39 and 40–59 year olds in intervention
communities (p < 0.05), while hip circumferences in-
creased significantly among 20–39 year olds (p < 0.05) in
intervention communities. Waist and hip circumference
decreased, though not significantly, among 20–39 year
olds in the comparison group. As a result, the net in-
crease in waist circumference was 3.0 cm (p < 0.001) and
2.0 cm (p = 0.03) in hip circumference among 20–39
year olds in intervention communities.
The waist-to-hip ratio of 20–39 (p < 0.001) and 40–59
year olds (p < 0.001) in the comparison group increased
significantly (Table 2). Waist-to-hip ratio remained un-
changed within intervention communities and the mag-
nitude of change did not differ between the intervention
and comparison group.
Discussion
A growing body of evidence indicates that unhealthy envi-
ronments, including ready availability, affordability and
convenience of energy-dense, nutrient-poor foods, and
limited opportunities for physical activity are major drivers
of unhealthy lifestyle behaviours and of attendant chronic
disease and obesity in Canada and globally [2, 15]. HAC
was a community-based intervention that sought to re-
duce risk factors for chronic disease and obesity through
leveraging the collective capacities of communities, aca-
demics and policy makers to tackle these risk drivers.
Study findings suggest that HAC-associated initiatives
positively impacted SBP and DBP and reduced the overall
prevalence of stage 1 hypertension across the four HAC
communities in comparison with national trends. By
contrast, anthropometric indicators remained largely
unchanged, and in some cases worsened in intervention
communities.
As one of the leading risk factors for stroke and is-
chaemic heart disease [6], and the leading risk factor for
global disability and death [9], reducing the population
prevalence of hypertension is an important public health
goal. Findings from this study demonstrate that signifi-
cant population-wide reductions in BP can be achieved
through relatively diffuse, community-led interventions.
The net reductions (change in intervention communities
minus change in the comparison group) in SBP observed
ranged from 1 to 2 mmHg, and from 2 to 3 mmHg for
DBP across the various age groups. BP reductions of this
magnitude can have positive health impacts, as a 2 mmHg
reduction in SBP can reduce mortality from stroke by
10 % and mortality from ischaemic heart disease by 7 %
[5], while lowering DBP by 5 mmHg can reduce the risk
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Table 2 Change in physical measures in intervention (HAC2006 and HAC2009) and comparison (CHMS2007-09 and CHMS2009-11) groups
Parameter Age
categories












Mean 95 % Confidence
interval
Mean 95 % Confidence
interval
Mean 95 % Confidence
interval
Mean 95 % Confidence
interval
from to from to from to from to
Mean systolic blood
pressure (mm Hg)
20–39 108 107 109 106 105 107 −2** 106 104 107 105 103 107 −1 0.006
40–59 115 114 116 112 111 113 −3*** 114 112 116 113 111 116 −1 0.001
60–79 126 124 128 123 121 125 −3* 125 124 126 124 122 125 −1 0.087
Mean diastolic blood
pressure (mm Hg)
20–39 71 70 72 68 68 69 −3*** 69 68 71 69 67 70 0 <0.001
40–59 76 76 77 73 72 73 −3*** 75 74 76 74 73 76 −1 <0.001
60–79 75 74 76 71 70 73 −4*** 73 72 73 72 71 73 −1 <0.001
Normal blood
pressuree (%)
18–39 90.6 88.2 92.9 93.9 92.1 95.7 3.3* 95.4 93.8 96.9 94.7 89.4 97.4 −0.7 0.029
40–59 76.3 72.9 79.7 85.2 82.5 87.9 8.9*** 82.4 78.8 85.9 82.7 77.4 86.9 0.3 <0.001
60–79 60.3 54.5 66.1 63.9 58.6 69.2 3.6 66.7 64.2 69.1 67.1 62.9 71.0 −0.6 0.403
18–79 79.1 77.0 81.1 84.7 83.0 86.5 5.6*** 84.4 82.8 86.0 84.1 80.7 87.0 −0.3 <0.001
High-normal blood
pressuree (%)
18–39 5.2 3.4 7.0 5.2 3.5 6.8 0 3.9 2.6 5.1 n/a … … … …
40–59 12.2 9.5 14.8 11.0 8.6 13.4 −1.2 11.3 8.7 13.9 9.3 6.8 12.6 −2.0 0.772
60–79 16.6 12.2 21.0 19.7 15.3 24.1 3.1 15.7 12.8 18.6 17.9 14.5 21.9 2.2 0.466
18–79 10.2 8.6 11.7 10.2 8.8 11.7 0 9.2 8.0 10.4 8.9 7.3 10.9 −0.3 0.895
Stage 1
hypertensione (%)
18–39 3.7 2.2 5.2 0.6 0 1.1 −3.1*** n/a … … n/a … … … …
40–59 8.8 6.5 11.1 2.7 1.5 .0 −6.1*** 5.3 4.0 6.6 6.5f 3.9 10.6 1.2 <0.001
60–79 16.7 12.3 21.2 13.9 10.1 17.8 −2.8 13.8 11.6 15.9 10.5 8.2 13.5 −3.3 0.638
18–79 8.2 6.8 9.7 4.0 3.0 4.9 −4.2*** 5.1 4.5 5.8 5.4 3.8 7.5 0.3 <0.001
Mean body
weight (kg)
20–39 77.5 75.9 79.2 79.4 77.8 81.0 1.9 76.0 74.2 77.7 75.6 72.5 78.7 −0.4 0.111
40–59 82.4 80.9 83.9 84.0 82.4 85.6 1.6 79.2 77.4 80.9 79.8 77.7 81.8 0.6 0.231
60–79 81.9 79.7 84.1 82.9 79.7 84.1 1.0 77.5 76.4 78.6 78.0 76.0 80.1 0.5 0.585
Mean BMI(kg/m2) 20–39 26.69 26.17 27.21 26.68 26.23 27.13 −0.01 26.20 25.64 26.77 25.87 25.09 26.65 −0.33 0.848
40–59 28.56 28.09 29.04 28.79 28.32 29.26 0.23 27.69 27.18 28.19 28.02 27.38 28.66 0.33 0.711
60–79 29.24 28.60 29.88 29.62 29.00 30.23 0.38 28.23 27.85 28.62 28.43 27.75 29.12 0.20 0.486
Normal weightg (%) 18–39 44.7 40.7 48.7 43.2 39.5 46.9 −1.5 48.2 42.8 53.7 49.7 43.3 56.2 1.5 0.532
40–59 29.6 25.9 33.3 28.7 25.2 32.1 −0.9 32.7 28.0 37.4 32.2 27.2 37.6 −0.5 0.777
60–79 20.4 15.6 25.1 20.6 16.1 25.0 0.2 27.9 22.5 33.3 25.6 19.9 32.3 −2.3 0.850













Table 2 Change in physical measures in intervention (HAC2006 and HAC2009) and comparison (CHMS2007-09 and CHMS2009-11) groups (Continued)
Overweightg(%) 18–39 32.3 28.5 36.1 32.0 28.5 35.4 −0.4 29.7 25.4 33.9 28.4 24.0 33.3 −1.3 0.978
40–59 35.9 32.0 39.8 36.5 32.8 40.2 0.6 41.4 38.0 44.8 37.4 31.1 44.1 −4.0 0.573
60–79 40.2 34.4 46.0 35.8 30.5 41.0 −4.4 41.2 37.2 45.3 38.8 34.0 43.9 −2.4 0.368
18–79 35.3 32.8 37.7 34.5 32.2 36.8 −0.8 36.7 33.7 39.7 34.2 30.9 37.7 −2.5 0.906
Obese, class Ig (%) 18–39 11.4 8.8 13.9 13.5 11.0 16.1 2.1 11.3 9.8 12.7 11.3 8.5 14.9 0 0.286
40–59 20.6 17.4 23.9 21.4 18.3 24.5 0.8 15.9 12.8 19.0 17.3 14.1 21.0 1.4 0.897
60–79 26.4 21.2 31.6 27.2 22.3 32.1 0.8 21.0 16.1 25.8 23.1 20.4 26.1 2.1 0.968
18–79 18.0 16.0 19.9 19.3 17.4 21.2 1.3 15.1 13.3 16.9 16.2 14.0 18.7 1.1 0.646
Obese, class IIg (%) 18–39 5.5 3.6 7.3 6.0 4.2 7.7 0.5 5.0 3.4 6.5 4.8f 2.8 8.1 −0.2 0.686
40–59 9.0 6.7 11.4 7.3 5.3 9.3 −1.7 6.3f 4.2 8.5 8.1f 5.2 12.5 1.8 0.189
60–79 8.1 4.9 11.4 11.7 8.1 15.2 3.6 6.5 4.5 8.5 5.9 4.5 7.8 −0.6 0.126
18–79 7.4 6.1 8.8 7.6 6.3 8.8 0.2 5.8 4.7 7.0 6.3 4.6 8.7 0.5 0.985
Obese, class IIIg (%) 18–39 3.5 2.0 5.0 2.4 1.2 3.5 −1.1 2.8f 1.6 4.0 2.7f 1.5 4.6 −0.1 0.286
40–59 4.3 2.7 6.0 5.8 4.0 7.6 1.5 3.2 2.2 4.2 4.2f 2.8 6.1 1.0 0.427
60–79 4.5 2.1 7.0 4.2 2.0 6.5 −0.3 3.0f 1.9 4.1 4.6f 2.8 7.5 1.6 0.645
18–79 4.0 3.0 5.1 4.1 3.2 5.1 0.1 3.0 2.3 3.7 3.7 2.8 4.8 0.7 0.671
Mean waist
circumference (cm)
20–39 86.6 85.2 88.0 88.4 87.3 89.6 1.8* 86.9 85.5 88.4 85.7 83.6 87.7 −1.2 <0.001
40–59 93.7 92.4 94.9 95.6 94.4 96.9 1.9* 93.4 91.9 94.9 93.8 92.1 95.6 0.4 0.062
60–79 97.9 96.1 99.8 99.3 97.6 101.0 1.4 97.6 96.2 98.9 97.3 95.4 99.1 −0.3 0.255
Mean hip
circumference (cm)
20–39 103.6 102.6 104.6 105.0 104.1 105.9 1.4* 102.7 101.5 103.8 102.1 100.5 103.7 −0.6 0.030
40–59 105.6 104.7 106.6 106.7 105.8 107.7 1.1 104.3 103.3 105.3 104.5 103.1 105.8 0.2 0.139
60–79 107.2 105.9 108.6 108.0 106.8 109.3 0.8 105.1 104.3 105.9 105.1 103.8 106.4 0 0.402
Mean waist/hip
ratio
20–39 0.83 0.82 0.84 0.84 0.83 0.84 0.01 0.84 0.84 0.85 0.86 0.85 0.86 0.02*** 0.807
40–59 0.88 0.88 0.89 0.89 0.89 0.90 0.01 0.89 0.89 0.90 0.91 0.90 0.92 0.02*** 0.518
60–79 0.91 0.90 0.92 0.92 0.91 0.93 0.01 0.93 0.92 0.94 0.93 0.93 0.94 0 0.206
CHMS Canadian Health Measures Survey; HAC: Healthy Alberta Communities
aValues were adjusted for age, community of residence, smoking status, physical activity level, fruit and vegetable consumption, self-reported health, and self-reported BMI
bTotal household population aged 18 to 79, except those meeting the CHMS exclusion criteria [78]
cValues are from the CHMS cycle 1 data tables [30]
dValues are from the CHMS cycle 2 data tables [11]
eBlood pressure (BP) was classified as normal (systolic BP < 130 mmHg and/or diastolic BP < 85 mmHg), high-normal (systolic BP = 130–139 mmHg and/or diastolic BP = 85–89 mmHg), or stage 1 hypertension (systolic
BP = 140–159 mmHg and/or diastolic BP = 90–99 mmHg) [32]
fUse with caution, data with a coefficient of variation from 16.6 % to 33.3 % [11, 30]
gBMI was calculated from measured height and weight and classified as: normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2), obese class I (30.0–34.9 kg/m2), obese class II (35.0–39.9 kg/m2), and obese
class III (≥40.0 kg/m2) [33]
n/aToo unreliable to be published, data with a coefficient of variation >33.3 %, suppressed due to extreme sampling variability [11, 30]













of stroke by 34 % and ischaemic heart disease by 21 %
[34]. As a result of these changes the population distribu-
tion of BP shifted to the left, with a net increase in the
proportion of normotensive individuals of 5.9 %, and a net
decrease in the proportion of stage 1 hypertensive individ-
uals of 4.5 %. These findings are encouraging in light of
persistently high rates of hypertension in Canada and glo-
bally [35, 36].
The mechanism underlying the BP reductions is un-
clear; however, given the prominent role of lifestyle-
related factors in BP homeostasis [13, 14], the targeting
of these risk factors through HAC initiatives, and the
stability in the proportion of participants in HAC com-
munities taking anti-hypertensive medications through-
out the study, changes in lifestyle-related behaviours are
likely implicated. Indeed, others have shown that antihy-
pertensive medications contributed to less than 25 % of
the decline in SBP observed in England between 1994
and 2009 [37]. Lifestyle modifications that effectively
lower BP include weight loss, reduced salt intake, con-
sumption of a DASH-style (Dietary Approaches to Stop
Hypertension) dietary pattern, increased potassium intake,
moderation of alcohol intake and increased physical activity
[13, 14]. Physical activity levels declined among individuals
in HAC communities, while BMI and fruit and vegetable
intake were unchanged [28], suggesting that a reduced so-
dium intake may have been a primary mechanism. A meta-
analysis of short-term sodium reduction trials demon-
strated a dose-responsive relationship between salt and BP,
with a 1 g/d decline in salt intake leading to a 1 mmHg fall
in SBP [38]. Although reduced alcohol consumption
and/or adoption of a DASH-style dietary pattern might
also be implicated, substantial changes in these areas
are more likely to have been accompanied by weight
loss. Notably, although alcohol intake increased in
Finland between 1970 and 1997, BP declined during
this period [39].
It is challenging to compare results across community-
based interventions given their unique contexts and
intervention strategies. Nevertheless, it is noteworthy
that a number of other community-based interventions
based on similar principles and strategies have also suc-
ceeded in reducing population-level BP. Between 1972
and 2007 in North Karelia, for instance, SBP declined by
11 mmHg in men and 19 mmHg in women, while DBP
decreased by 9 mmHg in men and 14 mmHg in women
(note that these values do not represent net reductions
as a true comparison group was not available in the later
Fig. 1 Change in mean systolic blood pressure within and between intervention and comparison groups. *p < 0.05 between follow-up and baseline
for intervention communities. **p < 0.01 between follow-up and baseline for intervention communities. ***p < 0.001 between follow-up and baseline
for intervention communities. &&p < 0.01 between follow-up and baseline changes in intervention and comparison groups. &&&p < 0.001 between
follow-up and baseline changes in intervention and comparison groups
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years of the study) [21, 39]. These declines have been at-
tributed to increased drug treatment and reductions in
calorie, salt, and fat intakes [40–43].
In the Stanford Three Community Study, 2 years of ex-
tensive mass media campaigns resulted in a substantial and
sustained reduction in BP within intervention communi-
ties, whereas the risk of cardiovascular disease based on
composite risk factor indices increased within the compari-
son community over the study period [44]. The subsequent
5-year Stanford Five-City Project led to net reductions in
BP ranging from 1.1 to 3.8 mmHg [45, 46]. In the former
West Germany, a 7-year community-oriented cardio-
vascular disease prevention project found a net reduc-
tion in mean SBP and DBP of 2 %, as compared with
the national trend [47], while a 5-year community-based
intervention in the Maastricht region of the Netherlands
also documented a significant reduction in SBP of
7.8 mmHg in men and 5.5 mmHg in women [48]. By
contrast, no changes in population-level BP were observed
in a number of other community-based interventions, in-
cluding the Minnesota Heart Health Program [49], the
Pawtucket Heart Health Program [50], the Women’s Life-
style Hart Trial [51], the Kilkenny Health Project [52] and
the Belgian Salt Intervention Trial [53].
One of the HAC’s primary goals was to reduce risk
factors for obesity. Although BMI did not decline within
intervention communities, it did remain stable over the
course of the study, a positive finding from an obesity
prevention perspective. However, BMI was also un-
changed in the comparison population, and thus it is
impossible to attribute this positive outcome to HAC-
associated interventions. Waist and hip circumference
increased in intervention communities within some age
groups, a disturbing trend given their association with
cardiovascular risk [54, 55]. Puzzling findings with re-
spect to anthropometric parameters were also observed
in the North Karelia project [41, 56, 57], the Stanford
Five-City Project [58], China’s Beijing Fangshan Cardio-
vascular Prevention Program [59], and the Isfahan
Health Heart Program in Iran [60]. Similarly, a meta-
analysis of six community-wide interventions to prevent
weight gain in children found only a very small reduction
in BMI z-score (-0.09, CI -0.16 to -0.02) among children in
intervention communities [61]. The well-known Fleurbaix-
Laventie study, a community-based intervention to reduce
childhood overweight and obesity in northern France, actu-
ally showed a non-significant trend toward an increased
prevalence of overweight during the first 8 years of the
study [62], a trend that was subsequently reversed in
later years [63]. In the Be Active Eat Well program in
Australia, large reductions in the prevalence of over-
weight/obesity in intervention and comparison commu-
nities appear to have occurred largely during the 3-year
post-intervention period [64].
Fig. 2 Change in diastolic blood pressure within and between intervention and comparison groups. ***p < 0.001 between follow-up and baseline
for intervention communities. &&&p < 0.001 between follow-up and baseline changes in intervention and comparison groups
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It is perhaps unsurprising that HAC failed to affect
BMI, as HAC devoted substantial efforts to community
capacity building and environmental change, an approach
unlikely to affect population-level body weights over a 3-
year period [22]. Whereas BP is influenced by a relatively
discrete set of factors and is readily modifiable through
pharmaceutical and lifestyle interventions [13, 38], body
weight is influenced by a complex array of interacting
factors and is highly resistant to change [65–67]. HAC-
associated interventions may not have been of sufficient
duration and intensity to change lifestyle behaviours to
the extent required to produce significant and sustained
community-wide energy deficits. Similarly, such interven-
tions could not likely counter the powerful influence of
existing food and physical activity environments that over-
whelmingly promote unhealthy behaviours. Survey results
support this interpretation, as physical activity levels
declined, and fruit and vegetable intake was unchanged
within HAC communities [28].
Future studies
Disappointing results from several community-based
interventions, along with the high cost of clinical risk
factor assessment, has led to the suggestion that more
realistic and proximal indicators of community change
should be emphasized within community-based inter-
ventions [22, 68, 69]. As Sorensen and colleagues [22]
have remarked, it is inappropriate to use clinical stan-
dards to judge the success of research conducted at a
population-level. Our findings are in keeping with this
recommendation. From the outset we recognized that
traditional health outcomes-focused evaluation methods
could not capture the value, context, and processes under-
lying this comprehensive initiative, and that change in
clinical risk factors would be difficult to detect at a
population-level within a 3-year time frame [27]. For this
reason, we assessed multiple indicators of community-
level change through evaluation of capacity building ac-
tivities [27, 70], social network analysis, and assessment
of environmental change (unpublished observations to
be presented in a forthcoming publication), as we antici-
pated these proximal indicators would likely demonstrate
change in advance of the more distal targets of health be-
haviours and outcomes. As expected, individual-level risk
factors changed only minimally [28], whereas community
environments (unpublished observations) and capacity for
health-related change improved significantly [27, 70]. Rich
contextual and process-related data also emerged [27, 70].
Fig. 3 Prevalence of normal blood pressure in intervention and comparison groups. Normal blood pressure was defined as systolic blood
pressure < 130 mmHg and/or diastolic blood pressure < 85 mmHg [32]. *p < 0.05 between follow-up and baseline for intervention communities.
***p < 0.001 between follow-up and baseline for intervention communities. &p < 0.05 between follow-up and baseline changes in intervention
and comparison groups. &&&p < 0.001 between follow-up and baseline changes in intervention and comparison groups
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In our estimation, the success of HAC and other
community-based interventions that prioritize environ-
mental and policy change should be judged principally
in terms of their success in doing so. While clinical out-
comes remain important to assess (particularly over
longer time frames) and are critical for mobilizing stake-
holder support and driving political action [71], they
should be regarded as secondary outcomes. Similarly,
Johnston et al. [72] have remarked that outcome goals
(such as obesity reduction targets) may be the wrong
goals, as they fail to account for natural feedback mecha-
nisms that act to resist weight loss, and can lead to unin-
tended consequences whereby interventions may be
deemed to have failed despite their potential to improve
overall health. Process-related goals, by contrast, may
prompt a deeper examination of environmental contexts
and opportunities for change within them [72]. Thus,
future community-based interventions could improve
resource allocation by channeling more resources into
interventions, and considering a truncated list of clinical
indicators complemented by community-level indicators
such as change in health-promoting environments and
policies, and process measures that capture the com-
plexity and richness of community change as it unfolds
[18]. These more comprehensive data can also be valuable
in attempts to link measurable change in environments
with key behavioural and health outcomes, enabling iden-
tification of interventions that ‘tip’ communities in health-
ful directions [73].
Strengths and limitations
HAC interventions were implemented in real-world
settings, with all of their constraints and supports, pro-
viding policy makers and practitioners with community-
tested evidence of impact and effectiveness. The physical
measures data are highly reliable as they are based on
objective assessments by trained measurement techni-
cians. Comparison data were from a nationally represen-
tative sample to allow the majority of research funds to
be dedicated to intervention activities, rather than creat-
ing costly and somewhat artificial comparison communi-
ties. Other community-based interventions have also
taken this approach [71]. Nevertheless, this strategy was
not without its limitations, as it precluded random as-
signment of communities to intervention and compari-
son conditions. The population-based sampling design
enhances the generalizability of the present findings,
however the use of repeated cross-sectional samples may
N/A
Fig. 4 Prevalence of stage 1 hypertension in intervention and comparison groups. Stage 1 hypertension was defined as systolic blood pressure
140–159 mmHg and/or diastolic blood pressure 90–99 mmHg [32]. ***p < 0.001 between follow-up and baseline in intervention communities. &&&p <
0.001 between follow-up and baseline changes in intervention and comparison groups. n/a = too unreliable to be published, data with a coefficient of
variation >33.3 %, suppressed due to extreme sampling variability [11, 30]
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have introduced bias due to sampling errors and the
low response rate to the telephone survey recruitment
strategy. Thus, it is not entirely clear whether the
changes that were observed in BP in HAC communities
are representative of the changes that would have oc-
curred had the intervention been implemented in all
Alberta communities. Socio-demographic characteris-
tics of individuals within the comparison group were
not available, and therefore we cannot assess the com-
parability of the intervention and comparison samples.
Identification of appropriately matched comparison
groups is always challenging within community-based
interventions, however [74]. Follow-up data within HAC
communities may be affected by in- and out-migration,
introducing new residents with limited or no exposure to
the interventions. The alternative approach of using a lon-
gitudinal cohort can be equally problematic, however, due
to high drop-out rates which limit representativeness [18].
In previous reports, we have emphasized that building
capacity for community health promotion is a process
that requires a sustained, long-term investment of time
and resources [70]. Although 3 years is a long duration
relative to many other similar studies, it is a relatively
short time frame within which to effect change in the
well-entrenched lifestyle behaviours and social norms of
entire communities. Indeed, Community Coordinators
indicated the project ended before they could fully realize
all of their objectives [70]. Thus, study findings represent
early indicators of change, and community-wide health
impacts may emerge over a longer time frame. HAC was a
capacity building intervention, and therefore Community
Coordinators worked to embed HAC-related activities
within existing community structures to ensure their sus-
tainability beyond the funding period [70]. Evidence sug-
gests that some of the initiatives developed through the
course of the study have been maintained [27], however it
is unclear whether the observed reductions in BP have
also been maintained.
Conclusions
Population-level, community-based interventions aim to
reduce the burden of disease through moderate risk re-
ductions across large population segments, as even small
shifts in the population distribution of health behaviours
can have sizeable impacts on population-level health
outcomes. The modest changes observed in this study,
including an increase in the proportion of individuals in
HAC communities with normal BP, and concurrent re-
duction in the proportion of individuals with stage 1
hypertension, suggest that HAC succeeded in shifting
the population distribution of BP in a leftward direction.
Notably, BP reductions were achieved in all age groups.
If such reductions are maintained, reductions in cardio-
vascular disease might become apparent over time. By
contrast, anthropometric indicators were unchanged and
in some cases worsened within intervention communi-
ties, highlighting the enormous challenge of improving
body weight in the context of pervasive obesogenic
environments.
Communities are complex, dynamic entities consisting
of individuals and organizations linked together by com-
mon physical, sociocultural, economic and political con-
texts. Producing change requires understanding how these
diverse environments interact to shape individual and col-
lective health-related behaviours, and developing interven-
tions to effectively leverage them in health-promoting
directions. The HAC experience highlights the complexity
of this endeavour and shows that communities, in part-
nership with academics and government, can effectively
mobilize to produce change in local environments on a
scale sufficient to impact population-level health out-
comes. However, whereas improvements in some clinical
risk factors can be achieved through relatively diffuse and
shorter-term community-level environmental change, im-
provements in others may require interventions of greater
intensity and duration. To better capture the wide ranging
benefits of community-based interventions the next gen-
eration of studies should measure proximal indicators of
community-level environmental change, and should seek
to understand the processes through which change occurs.
Community-based interventions should not gauge their
success merely in terms of their efficacy in changing
shorter-term individual-level clinical health outcomes.
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